ghk-cu daily 5mg ghk cu 50mg Quicksilver Liposomal Copper GHK – – Neurogan GHK-Cu + AHK-Cu Hair

Cell and Tissue Research, 377(2), 153-159

Its derivative, Kojic Dipalmitate, was developed as a stable alternative

Doses Per Vial Vial duration varies by dose and escalation phase: 5mg vial: At 0.5mg/week = 10 weeks (starting phase) At 1mg/week = 5 weeks At 2mg/week = 2.5 weeks At 4mg/week = 1.25 weeks 10mg vial: At 2mg/week = 5 weeks At 4mg/week = 2.5 weeks At 8mg/week = 1.25 weeks At 12mg/week = less than 1 week For the escalation phase (0.5mg to 4mg), a single 5mg vial typically covers the first several weeks

The occipital artery and the pterygopalatine artery (PPA) were permanently ligated

References & further reading PubMed 34324435 MDPI 2876 Quality in Sport 70818 Springer s00441-019-03016-8 ScienceDirect S875632829800180X DOI 10.2147/DDDT.S82030 MDPI 291 Nature s41598-026-55449-1 Springer s12178-025-09990-7 This product is intended strictly for in-vitro laboratory research and analytical reference use